    <SEC-DOCUMENT>0001628280-24-010870-index.html : 20240313
    <SEC-HEADER>0001628280-24-010870.hdr.sgml : 20240313
    <ACCEPTANCE-DATETIME>20240313151912
    ACCESSION NUMBER:		0001628280-24-010870
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20231231
    FILED AS OF DATE:		20240313
    DATE AS OF CHANGE:		20240313
    EFFECTIVENESS DATE:		20240313

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			ADC Therapeutics SA
    		CENTRAL INDEX KEY:			0001771910
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				000000000
    		STATE OF INCORPORATION:			V8
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-39071
    		FILM NUMBER:		24745771

    	BUSINESS ADDRESS:
    		STREET 1:		BIOPOLE
    		STREET 2:		ROUTE DE LA CORNICHE 3B
    		CITY:			EPALINGES
    		STATE:			V8
    		ZIP:			1066
    		BUSINESS PHONE:		41 21 653 02 00

    	MAIL ADDRESS:
    		STREET 1:		BIOPOLE
    		STREET 2:		ROUTE DE LA CORNICHE 3B
    		CITY:			EPALINGES
    		STATE:			V8
    		ZIP:			1066
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>adct2023annualreport_filin.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: adct2023annualreport_filin.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>